ARCS Australia Ltd, the peak body representing professionals in the MedTech and Pharmaceutical sector, this week announced a series of significant changes at its annual conference.
Dr Tim Boyle, CEO of ARCS Australia Ltd speaking to Australian Health Journal says, “These initiatives are central to strategy to build professionalism within the sector, increase capability and enhance the professional standing of its members.”
ARCS has launched a comprehensive Core Competency Framework tailored for the Medtech and Pharmaceutical sectors. The framework is designed to ensure members possess the specialised knowledge and skills required to excel within the sector, aiming to set benchmark for professional excellence.
“Our Core Competency Framework is a milestone in our journey to elevate professional standards for those working within the sector,” said Dr Boyle,. “It provides a structured pathway for continuous professional development common to all sectorial occupations and ensures our members are equipped with the expertise needed to meet professional demands.”
Expanding upon the Core Competency Framework, ARCS has also established international partnerships with the Association of Clinical Research Professionals (ACRP), the Regulatory Affairs Professionals Society (RAPS), and the International Society of Pharmacovigilance (ISoP) to recognise their occupation specific competency frameworks and accreditation standards. These partnerships aim to facilitate the creation of professional training pathways aligned with globally recognised best practice for sectorial occupations.
“Our alliances with ACRP, RAPS, and ISoP are pivotal in offering our members access to globally recognised professional pathways and raising the standard of Australian professionals through globally recognised professional accreditation,” said Dr Boyle.
“These collaborations help raise the bar and advance the professional standing of Australian Medtech and Pharmaceutical professionals on a global playing field.”
In recognition of professional excellence, ARCS will now issue postnominals to professional members based on their expertise. The aim of this designation is to underscore a member’s commitment to the highest standards of practice and their specialised expertise.
“The initiatives we are announcing today mark a new era for ARCS,” Dr Boyle concluded. “By establishing a robust competency framework, recognising professional excellence through postnominals, fostering international collaborations, and honouring our distinguished Fellows, we are setting a new standard for professionalism within the Australian Medtech and Pharmaceutical sectors.”
-
Updated handbook on chronic kidney disease management in primary care
Kidney Health Australia’s latest kidney disease guide for primary care practitioners is expected to be pivotal in slowing down the rates of kidney failure, which have doubled in the past 20 years and if left unchecked will grow by a further 42% by 2030, according to the health charity.
With specific reference to new kidney treatments and culturally safe kidney care for First Nations Australians, the 5th edition of Chronic Kidney Disease (CKD) Management in Primary Care handbook, known as the ‘kidney bible’, is a significant step-up in enabling earlier diagnosis of kidney disease for GPs and other front-line healthcare professionals.
-
Victorian social prescribing program underway
n Part 2 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people involved in the Connect Local program under the Connecting Communities to Care 4 year program. The free program for over 65’s promotes wellbeing through social connection and is underway in the Glen Eira community in Melbourne.
– Deidre McGill, Executive General Manager, At Home Support, Bolton Clarke
– Ann Van Leerdam, Connect Local Community Connector, Bolton Clarke
– Dr Rajna Ogrin, Senior Research Fellow, Bolton Clarke Research Institute, Bolton Clarke - Dr Daniel Fineberg, Deputy Director General Medicine, Alfred Hospital, Victoria -
Targeted National Lung Cancer Screening Program commences in 2025
In February 2025, Australian Health Journal spoke with Mark Brooke, Chief Executive Officer of Lung Foundation Australia, at the 10th Australian Lung Cancer Conference in Adelaide, on the upcoming commencement of the National Lung Cancer Screening Program (NLCSP)
